Elina Armstrong
Helsinki University Hospital · 59 works · 2,598 citations · h-index 23
Top works
- A Novel Endothelial Cell Surface Receptor Tyrosine Kinase with Extracellular Epidermal Growth Factor Homology Domains
- Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization
- Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts.
- A radiation hybrid map of 18 growth factor, growth factor receptor, hormone receptor, or neurotransmitter receptor genes on the distal region of the long arm of chromosome 5
- FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter.
- cyl encodes a putative cytoplasmic tyrosine kinase lacking the conserved tyrosine autophosphorylation site (Y416src).
- Amplification of fgfr4 gene in human breast and gynecological cancers
- Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
- Diverse receptors for fibroblast growth factors
- Role of Vector in Activation of T Cell Subsets in Immune Responses against the Secreted Transgene Product Factor IX
- Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene Therapy
- Expression of tie receptor tyrosine kinase in leukemia cell lines.
- Risk and Prevention of Anti-factor IX Formation in AAV-Mediated Gene Transfer in the Context of a Large Deletion of F9
- Successful Liver-Kidney Transplantation in Two Children With aHUS Caused by a Mutation in Complement Factor H
- Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn
- Clinical significance of the del(20q) chromosome in hematologic disorders
- Expression of fibroblast growth factor receptors in human leukemia cells.
- Localization of the fibroblast growth factor receptor‐4 gene to chromosome region 5q33‐qter
- Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice
- Active Online Assessment of Patients Using New Oral Anticoagulants: Bleeding Risk, Compliance, and Coagulation Analysis